BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26782430)

  • 1. Pooled analysis of association between a genetic variant in the 3'-untranslated region of Toll-like receptor 4 and cancer risk.
    Wang X; Xu Z; Miao CH
    Genet Mol Res; 2015 Dec; 14(4):17847-55. PubMed ID: 26782430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One functional variant in the 3'-untranslated region of TLR4 is associated with the elevated risk of ventilator-associated pneumonia in the patients with chronic obstructive pulmonary disease.
    Zhao X; Feng J; Zhang L; Zhao F; Li M; Du Y; Li Y; Wu Q; Li G
    J Cell Physiol; 2019 Aug; 234(10):18879-18886. PubMed ID: 30972742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TLR4 gene polymorphisms and susceptibility to cancer: a systematic review and meta-analysis.
    Zhang K; Zhou B; Wang Y; Rao L; Zhang L
    Eur J Cancer; 2013 Mar; 49(4):946-54. PubMed ID: 23084080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men.
    Kim HJ; Bae JS; Chang IH; Kim KD; Lee J; Shin HD; Lee JY; Kim WJ; Kim W; Myung SC
    World J Urol; 2012 Apr; 30(2):225-32. PubMed ID: 21553150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
    Lindström S; Hunter DJ; Grönberg H; Stattin P; Wiklund F; Xu J; Chanock SJ; Hayes R; Kraft P
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):873-6. PubMed ID: 20200442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
    Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.
    Zheng SL; Augustsson-Bälter K; Chang B; Hedelin M; Li L; Adami HO; Bensen J; Li G; Johnasson JE; Turner AR; Adams TS; Meyers DA; Isaacs WB; Xu J; Grönberg H
    Cancer Res; 2004 Apr; 64(8):2918-22. PubMed ID: 15087412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single nucleotide polymorphism in 3'-untranslated region contributes to the regulation of Toll-like receptor 4 translation.
    Sato K; Yoshimura A; Kaneko T; Ukai T; Ozaki Y; Nakamura H; Li X; Matsumura H; Hara Y; Ogata Y
    J Biol Chem; 2012 Jul; 287(30):25163-72. PubMed ID: 22661708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing an association between TLR4 and CXCR1 gene polymorphisms with susceptibility to urinary tract infection in type 2 diabetes in north Indian population.
    Gond DP; Singh S; Agrawal NK
    Gene; 2018 Jan; 641():196-202. PubMed ID: 29066305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Effect of Variants in Toll-like Receptor 4 Gene in Saudi Patients with Type 2 Diabetes Mellitus.
    Alkudmani ZS; Alshammary AF; Ali Khan I
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TLR2 and TLR4 non-missense single nucleotide polymorphisms with type 2 diabetes risk in a southern Chinese population: a case-control study.
    Huang WH; Nie LH; Zhang LJ; Jing LP; Dong F; Wang M; Zhang N; Liu Y; Zhang BH; Chen C; Lin HS; Wei XC; Yang G; Jing CX
    Genet Mol Res; 2015 Jul; 14(3):8694-705. PubMed ID: 26345801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of TLR2 and TLR4 polymorphisms with risk of cancer: a meta-analysis.
    Zhu L; Yuan H; Jiang T; Wang R; Ma H; Zhang S
    PLoS One; 2013; 8(12):e82858. PubMed ID: 24376595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.
    Weng PH; Huang YL; Page JH; Chen JH; Xu J; Koutros S; Berndt S; Chanock S; Yeager M; Witte JS; Eeles RA; Easton DF; Neal DE; Donovan J; Hamdy FC; Muir KR; Giles G; Severi G; Smith JR; Balistreri CR; Shui IM; Chen YC
    PLoS One; 2014; 9(10):e110569. PubMed ID: 25360682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of polymorphisms in Toll-like receptors 4 and 9 with risk of pulmonary tuberculosis: a meta-analysis.
    Zhao L; Liu K; Kong X; Tao Z; Wang Y; Liu Y
    Med Sci Monit; 2015 Apr; 21():1097-106. PubMed ID: 25889916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between
    Zerrad C; Lkhider M; Belkouchi A; Tanouti IA; Badre W; Tahiri M; Ayassi S; Marchio A; Pineau P; Benjelloun S; Ezzikouri S
    Nucleosides Nucleotides Nucleic Acids; 2023; 42(12):986-1003. PubMed ID: 37330637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the Relationship Between rs4986790 and rs4986791 Variants of TLR4 Gene and Lung Cancer.
    Kurt H; Ozbayer C; Bayramoglu A; Gunes HV; Degirmenci İ; Oner KS; Metintas M
    Inflammation; 2016 Feb; 39(1):166-171. PubMed ID: 26299699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 4 genetic variation and advanced prostate cancer risk.
    Cheng I; Plummer SJ; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):352-5. PubMed ID: 17301271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between TLR4 A299G polymorphism and pneumonia risk: a meta-analysis.
    Cai X; Fu Y; Chen Q
    Med Sci Monit; 2015 Feb; 21():625-9. PubMed ID: 25720378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
    Kutikhin AG
    Hum Immunol; 2011 Feb; 72(2):193-206. PubMed ID: 21081146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.